Cite

HARVARD Citation

    McCormick, M. et al. (2022). Reply to: Comment on: "Premedication prior to PEG‐asparaginase is cost effective in pediatric patients with acute lymphoblastic leukemia". Pediatric blood & cancer. 69 (11), p. n/a. [Online]. 
  
Back to record